237 related articles for article (PubMed ID: 15356118)
1. Stimulatory killer Ig-like receptors modulate T cell activation through DAP12-dependent and DAP12-independent mechanisms.
Snyder MR; Nakajima T; Leibson PJ; Weyand CM; Goronzy JJ
J Immunol; 2004 Sep; 173(6):3725-31. PubMed ID: 15356118
[TBL] [Abstract][Full Text] [Related]
2. Selective activation of the c-Jun NH2-terminal protein kinase signaling pathway by stimulatory KIR in the absence of KARAP/DAP12 in CD4+ T cells.
Snyder MR; Lucas M; Vivier E; Weyand CM; Goronzy JJ
J Exp Med; 2003 Feb; 197(4):437-49. PubMed ID: 12591902
[TBL] [Abstract][Full Text] [Related]
3. Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis.
Namekawa T; Snyder MR; Yen JH; Goehring BE; Leibson PJ; Weyand CM; Goronzy JJ
J Immunol; 2000 Jul; 165(2):1138-45. PubMed ID: 10878393
[TBL] [Abstract][Full Text] [Related]
4. De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes.
Nakajima T; Goek O; Zhang X; Kopecky SL; Frye RL; Goronzy JJ; Weyand CM
Circ Res; 2003 Jul; 93(2):106-13. PubMed ID: 12816883
[TBL] [Abstract][Full Text] [Related]
5. IL-4 confers NK stimulatory capacity to murine dendritic cells: a signaling pathway involving KARAP/DAP12-triggering receptor expressed on myeloid cell 2 molecules.
Terme M; Tomasello E; Maruyama K; Crépineau F; Chaput N; Flament C; Marolleau JP; Angevin E; Wagner EF; Salomon B; Lemonnier FA; Wakasugi H; Colonna M; Vivier E; Zitvogel L
J Immunol; 2004 May; 172(10):5957-66. PubMed ID: 15128777
[TBL] [Abstract][Full Text] [Related]
6. Formation of the killer Ig-like receptor repertoire on CD4+CD28null T cells.
Snyder MR; Muegge LO; Offord C; O'Fallon WM; Bajzer Z; Weyand CM; Goronzy JJ
J Immunol; 2002 Apr; 168(8):3839-46. PubMed ID: 11937537
[TBL] [Abstract][Full Text] [Related]
7. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M
Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
[TBL] [Abstract][Full Text] [Related]
8. Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection.
Sjölin H; Tomasello E; Mousavi-Jazi M; Bartolazzi A; Kärre K; Vivier E; Cerboni C
J Exp Med; 2002 Apr; 195(7):825-34. PubMed ID: 11927627
[TBL] [Abstract][Full Text] [Related]
9. Contrasting roles of DAP10 and KARAP/DAP12 signaling adaptors in activation of the RBL-2H3 leukemic mast cell line.
Anfossi N; Lucas M; Diefenbach A; Bühring HJ; Raulet D; Tomasello E; Vivier E
Eur J Immunol; 2003 Dec; 33(12):3514-22. PubMed ID: 14635062
[TBL] [Abstract][Full Text] [Related]
10. KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions.
Tomasello E; Vivier E
Eur J Immunol; 2005 Jun; 35(6):1670-7. PubMed ID: 15884055
[TBL] [Abstract][Full Text] [Related]
11. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic.
Ferlazzo G; Thomas D; Lin SL; Goodman K; Morandi B; Muller WA; Moretta A; Münz C
J Immunol; 2004 Feb; 172(3):1455-62. PubMed ID: 14734722
[TBL] [Abstract][Full Text] [Related]
12. Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice.
Tomasello E; Desmoulins PO; Chemin K; Guia S; Cremer H; Ortaldo J; Love P; Kaiserlian D; Vivier E
Immunity; 2000 Sep; 13(3):355-64. PubMed ID: 11021533
[TBL] [Abstract][Full Text] [Related]
13. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns.
Uhrberg M; Valiante NM; Young NT; Lanier LL; Phillips JH; Parham P
J Immunol; 2001 Mar; 166(6):3923-32. PubMed ID: 11238637
[TBL] [Abstract][Full Text] [Related]
14. Syk regulation of phosphoinositide 3-kinase-dependent NK cell function.
Jiang K; Zhong B; Gilvary DL; Corliss BC; Vivier E; Hong-Geller E; Wei S; Djeu JY
J Immunol; 2002 Apr; 168(7):3155-64. PubMed ID: 11907067
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.
André P; Castriconi R; Espéli M; Anfossi N; Juarez T; Hue S; Conway H; Romagné F; Dondero A; Nanni M; Caillat-Zucman S; Raulet DH; Bottino C; Vivier E; Moretta A; Paul P
Eur J Immunol; 2004 Apr; 34(4):961-71. PubMed ID: 15048706
[TBL] [Abstract][Full Text] [Related]
16. 2B4 (CD244)-mediated activation of cytotoxicity and IFN-gamma release in human NK cells involves distinct pathways.
Chuang SS; Kumaresan PR; Mathew PA
J Immunol; 2001 Dec; 167(11):6210-6. PubMed ID: 11714782
[TBL] [Abstract][Full Text] [Related]
17. DAP12-based activating chimeric antigen receptor for NK cell tumor immunotherapy.
Töpfer K; Cartellieri M; Michen S; Wiedemuth R; Müller N; Lindemann D; Bachmann M; Füssel M; Schackert G; Temme A
J Immunol; 2015 Apr; 194(7):3201-12. PubMed ID: 25740942
[TBL] [Abstract][Full Text] [Related]
18. The gp49B1 inhibitory receptor regulates the IFN-gamma responses of T cells and NK cells.
Gu X; Laouar A; Wan J; Daheshia M; Lieberman J; Yokoyama WM; Katz HR; Manjunath N
J Immunol; 2003 Apr; 170(8):4095-101. PubMed ID: 12682239
[TBL] [Abstract][Full Text] [Related]
19. Killer cell immunoglobulin receptor profile on CD4(+) CD28(-) T cells and their pathogenic role in non-dialysis-dependent and dialysis-dependent chronic kidney disease patients.
Zal B; Chitalia N; Ng YS; Trieu V; Javed S; Warrington R; Kaski JC; Banerjee D; Baboonian C
Immunology; 2015 May; 145(1):105-13. PubMed ID: 25484131
[TBL] [Abstract][Full Text] [Related]
20. IL-18 activates STAT3 in the natural killer cell line 92, augments cytotoxic activity, and mediates IFN-gamma production by the stress kinase p38 and by the extracellular regulated kinases p44erk-1 and p42erk-21.
Kalina U; Kauschat D; Koyama N; Nuernberger H; Ballas K; Koschmieder S; Bug G; Hofmann WK; Hoelzer D; Ottmann OG
J Immunol; 2000 Aug; 165(3):1307-13. PubMed ID: 10903731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
